Suscribirse

Case-control study evaluating risk factors for SARS-CoV-2 outbreak amongst healthcare personnel at a tertiary care center - 18/11/21

Doi : 10.1016/j.ajic.2021.09.004 
Joelle I Rosser, MD, MS a, 1, , Ralph Tayyar, MD a, 1, Richard Giardina, MPH, RN, CIC, FACHE b, Peter Kolonoski, RN, MSN, CIC b, Diane Kenski, MPH, RN, CIC b, Peidong Shen, PhD a, Lars M Steinmetz, PhD a, Li-Yuan Hung, MS c, Wenzhong Xiao, PhD c, Karen Bains, CEL, LVN b, Timothy Morrison, EdD b, Alexandra Madison, MPH b, Sang-ick Chang, MD, MPH b, Lucy Tompkins, MD, PhD a, b, Benjamin A Pinsky, MD, PhD a, Marisa Holubar, MD, MS a, b
a Division of Infectious Diseases & Geographic Medicine, Stanford University School of Medicine, Stanford, CA 
b Stanford Health Care, Stanford, CA 
c Immune-Metabolism Computational Center, Massachusetts General Hospital, Harvard Medical School, Cambridge, MA 

Address correspondence to Joelle I Rosser, MD, MS, Division of Infectious Diseases & Geographic Medicine, Stanford University School of Medicine, 300 Pasteur Dr., L-134, Stanford, CA 94305.Division of Infectious Diseases & Geographic MedicineStanford University School of Medicine300 Pasteur Dr., L-134StanfordCA94305

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Repeat SARS-CoV-2 testing after admission is key in suspicious cases
Whole genome sequencing can assist with outbreak investigations
Increased patient contact time is a risk factor for nosocomial SARS-CoV-2 infection
Performing aerosol-generating procedures increases nosocomial SARS-CoV-2 risk

El texto completo de este artículo está disponible en PDF.

Abstract

Background

Despite several outbreaks of SARS-CoV-2 amongst healthcare personnel (HCP) exposed to COVID-19 patients globally, risk factors for transmission remain poorly understood.

Methods

We conducted an outbreak investigation and case-control study to evaluate SARS-CoV-2 transmission risk in an outbreak among HCP at an academic medical center in California that was confirmed by whole genome sequencing.

Results

A total of 7/9 cases and 93/182 controls completed a voluntary survey about risk factors. Compared to controls, cases reported significantly more patient contact time. Cases were also significantly more likely to have performed airway procedures on the index patient, particularly placing the patient on high flow nasal cannula, continuous positive airway pressure (CPAP), or bilevel positive airway pressure (BiPAP) (OR = 11.6; 95% CI = 1.7 –132.1).

Discussion

This study highlights the risk of nosocomial infection of SARS-CoV-2 from patients who become infectious midway into their hospitalization. Our findings also reinforce the importance of patient contact time and aerosol-generating procedures as key risk factors for HCP infection with SARS-CoV-2.

Conclusions

Re-testing patients for SARS-CoV-2 after admission in suspicious cases and using N95 masks for all aerosol-generating procedures regardless of initial patient SARS-CoV-2 test results can help reduce the risk of SARS-COV-2 transmission to HCP.

El texto completo de este artículo está disponible en PDF.

Key Words : SARS-CoV-2, COVID-19, Healthcare personnel, Outbreak, Case-control study, Whole genome sequencing, contact tracing, Epidemiology, Aerosol generating procedure


Esquema


 Funding/support: J.I.R. is supported by NIH Training Grant 5T32AI052073-14 and by a Stanford University Maternal Child Health Research Institute grant. P.S., L.H., and W.X. are supported by funding from Open Medicine Foundation. None of the authors received financial or material support for the research and work in this manuscript.
 Conflicts of interest: None of the authors have any relevant conflict of interest or other financial disclosures relevant to the subject matter.
 Authors’ contributions: J.I.R. and R.T. equally contributed to this paper with study design, literature review and analysis, drafting and critical revision of the manuscript. R.G., P.K., D.K, S.C, K.B, T.M., A.M., and L.T. assisted with data acquisition, outbreak investigation, survey design, and critical review of the manuscript. B.A.P., P.S., L.S., L.H., and W.X. performed molecular sequencing and tracing, assisted with drafting and critical review of the manuscript. M.H. supervised the project, was involved in study and survey design, analysis, drafting and critical review of the manuscript.


© 2021  Association for Professionals in Infection Control and Epidemiology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 49 - N° 12

P. 1457-1463 - décembre 2021 Regresar al número
Artículo precedente Artículo precedente
  • Information for Authors
| Artículo siguiente Artículo siguiente
  • Impact of In-Hospital infection with SARS-CoV-2 among Inpatients at a university hospital
  • Josni Tauffer, Thais Claudia Roma de Oliveira Konstantyner, Maria Claudia Stockler de Almeida, Diogo Boldim Ferreira, Thaysa Sobral Antonelli, Dayana Souza Fram, Daniela Vieira Escudero, Paulo Roberto Abrão Ferreira, Nancy Bellei, Arnaldo Lopes Colombo, Suely Miyuki Yashiro, Antonia Maria de Oliveira Machado, Eduardo Alexandrino Medeiros

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.